UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Life Science

The Emerging Market of the Human Microbiome

The human microbiome is an area of life sciences that is gaining traction in the venture capital community. According to the Wall Street Journal, venture capital investment in microbiome companies rose 458.5 percent to 114.5 million U.S. dollars during the period from 2011 – 2015.

Read More

Digital Pathology Goes Mobile

Medical Applications on Smartphones

Mobile technology could act as a radical stimulus in aiding digital pathology on to a totally new level in remitting and delivering clinical diagnostics.

Read More

Lifestyle Interventions in NASH – Backbone, Therapy or Waste of Time?

The effects of lifestyle interventions as a baseline therapy for the treatment of NASH are well accepted. However, there is a high degree of frustration when it comes to recommending and implementing lifestyle changes. Large interventional studies in the field of metabolic disease are largely negative with regards to long-term outcomes.

Read More

How Digital Technologies are disrupting Healthcare

Intellectual Property (IP) has always been a key building block for successful healthcare businesses. However, as blockbuster patents on small molecules are becoming a thing of the past, IP in healthcare will need to evolve to meet the challenges of tomorrow. This is particularly important when considering the opportunities and challenges presented by the digital revolution, often referred to as Industry 4.0.

Read More

Microbiome-based interventions – a labyrinth of modalities

Microbiome-based interventions, whether therapeutic or prophylactic, come in a broad spectrum of modalities, a consequence of the complexity of and possibilities afforded by the microbiome.

Read More

Tele-Consultation Systems for Today’s Pathologists

Pathology is dealing with an area of diagnostics that is extremely variable. General pathologists are able to diagnose virtually any disease, but in rare or complex cases it is common practice to consult an expert.

Read More

Antibody Drug Conjugates: Bioanalytical Assay Challenges and Strategies

Antibody-drug conjugates (ADCs) combine the high specificity of a monoclonal antibody (mAb) for a target antigen with the highly potent cytotoxic activity of small-molecule drugs. Although the concept behind ADCs is relatively simple, the successful design and development of ADCs is a complex task. Similar to other biotherapeutics, the understanding of Pharmacokinetics (PK), Pharmacodynamics (PD), and Absorption, Distribution, Metabolism, and Excretion (ADME) properties of ADCs is critical for their successful development.

Read More

Big Data Analytics and Artificial Intelligence: 7 Design Principles to Empower Life Science Researchers

Life sciences research is increasingly relying on big data analytics to drive scientific discovery. One of the contributing factors to this trend is the fact that researchers are confronted with a rapidly growing body of scientific literature and databases required to interpret experimental outcomes.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive